Clatterbridge has been treating Terry Hodsgon for liver cancer since 2013. He is the first patient in the UK to take part in a new trial that is designed to build up the immune system to recognise and destroy cancer cells that have already become resistant to chemotherapy and radiotherapy.

“The care I’ve received at The Clatterbridge Cancer Centre has been absolutely outstanding. From the receptionists right through to my consultant, Professor Palmer. Putting aside why I’m there, Clatterbridge is a truly wonderful place made special by the staff”.